Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ZOOZ Strategy (ZOOZ) Cash & Equivalents (2022 - 2025)

ZOOZ Strategy filings provide 4 years of Cash & Equivalents readings, the most recent being $27.0 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 258.84% to $27.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.0 million, a 258.84% increase, with the full-year FY2025 number at $27.0 million, up 258.84% from a year prior.
  • Cash & Equivalents hit $27.0 million in Q4 2025 for ZOOZ Strategy, up from $2.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $27.0 million in Q4 2025 to a low of $2.5 million in Q2 2025.
  • Median Cash & Equivalents over the past 4 years was $7.6 million (2024), compared with a mean of $12.0 million.
  • The widest YoY moves for Cash & Equivalents: up 258.84% in 2025, down 68.24% in 2025.
  • ZOOZ Strategy's Cash & Equivalents stood at $20.8 million in 2022, then crashed by 67.91% to $6.7 million in 2023, then rose by 12.89% to $7.5 million in 2024, then soared by 258.84% to $27.0 million in 2025.
  • The last three reported values for Cash & Equivalents were $27.0 million (Q4 2025), $2.5 million (Q2 2025), and $7.5 million (Q4 2024) per Business Quant data.